Company Valuation: Axsome Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,424 3,349 3,766 4,100 9,207 7,207 - -
Change - 135.22% 12.44% 8.87% 124.55% -21.73% - -
Enterprise Value (EV) 1 1,387 3,243 3,558 3,966 9,072 7,054 6,781 6,389
Change - 133.87% 9.72% 11.46% 128.76% -22.25% -3.87% -5.79%
P/E -10.9x -16.8x -15.1x -14.1x -49.6x -53.9x 39.7x 13.4x
PBR 90.9x 30.6x 19.7x 72.2x 105x 75.4x 33.2x 12.3x
PEG - -0.5x -1x -1x 1.3x 1.7x -0x 0x
Capitalization / Revenue - 66.9x 13.9x 10.6x 14.4x 7.55x 4.93x 3.49x
EV / Revenue - 64.8x 13.1x 10.3x 14.2x 7.39x 4.64x 3.09x
EV / EBITDA -11.1x -18.5x -15.8x -14.5x -56.7x -59.2x 51.7x 17.9x
EV / EBIT -11.1x -18x -15.3x -14.1x -54.4x -55.9x 33x 9.75x
EV / FCF -12.8x -27.7x -24.4x -30.8x -96.6x -37.6x 19.3x 9.1x
FCF Yield -7.83% -3.61% -4.09% -3.24% -1.03% -2.66% 5.18% 11%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -3.47 -4.6 -5.27 -5.99 -3.68 -2.54 3.453 10.23
Distribution rate - - - - - - - -
Net sales 1 - 50.04 270.6 385.7 638.5 954.3 1,461 2,066
EBITDA 1 -124.6 -175.4 -225 -273.6 -159.9 -119.1 131.2 356.3
EBIT 1 -124.7 -179.8 -231.8 -280.6 -166.8 -126.2 205.7 655.1
Net income 1 -130.4 -187.1 -239.2 -287.2 -183.2 -132.1 191.6 580.3
Net Debt 1 -37.38 -106.6 -208.1 -134.6 -135.2 -152.9 -425.6 -818
Reference price 2 37.78 77.13 79.59 84.61 182.64 137.01 137.01 137.01
Nbr of stocks (in thousands) 37,692 43,426 47,320 48,462 50,413 52,600 - -
Announcement Date 01/03/22 27/02/23 20/02/24 18/02/25 23/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-53.94x7.39x-59.22x-.--% 7.21B
41.9x14.18x30.07x0.48% 1,275B
41.35x6.94x19.51x1.89% 680B
37.55x8.61x17.78x2.34% 521B
22x5.33x13.34x2.45% 389B
102.54x5.86x24.97x2.35% 356B
24.41x5.87x14.28x2.7% 305B
24.28x4.86x13.64x1.8% 287B
23.87x7.33x13.47x2.18% 250B
-39.41x7.29x45.94x1.97% 208B
Average 22.45x 7.37x 13.38x 1.82% 428B
Weighted average by Cap. 36.93x 8.89x 22.37x 1.68%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Axsome Therapeutics, Inc.

Historical PBR trend

Valuation ratios - PBR - Axsome Therapeutics, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Axsome Therapeutics, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Axsome Therapeutics, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Axsome Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. AXSM Stock
  4. Valuation Axsome Therapeutics, Inc.